DETERMINANTS OF EVALUATION OF BIOLOGICAL ASSETS AT FAIR VALUE IN COMPANIES LISTED ON THE BM&FBOVESPA
This study aims to answer the following research question: What is the influence of economic and financial indicators in the assessment of biological assets at fair value in companies listed on the BM & FBOVESPA after the adoption of CPC 29? A descriptive research aims to identify the influe...
Na minha lista:
Principais autores: | Brizolla, Maria Margarete Baccin, Pletsch, Caroline Sulzbach, Fasolin, Luiza Betânia, Silva, Alini da, Rosa, Fabrícia Silva da |
---|---|
Formato: | Online |
Idioma: | por |
Publicado em: |
Portal de Periódicos Eletrônicos da UFRN
|
Endereço do item: | https://periodicos.ufrn.br/ambiente/article/view/4989 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
PERFORMANCE INDICATORS AND MARKET VALUE: AN ANALYSIS ON THE COMPANIES LISTED IN BM&FBOVESPA
por: Oliveira, José Felipe da Rocha, et al.
Publicado em: (2017) -
MARKET VALUE AND VOLUNTARY DISCLOSURE: AN EMPIRICAL STUDY IN COMPANIES LISTED ON BM&FBOVESPA
por: de Sousa, Claudinéia Boaventura, et al.
Publicado em: (2014) -
STATEMENT OF VALUE ADDED: THE EVOLUTION AND DISTRIBUTION OF THE WEALTH OF SANTA CATARINA COMPANIES LISTED ON THE BM&FBOVESPA
por: Guesser, Ana Paula Günther, et al.
Publicado em: (2018) -
INTANGIBILITY LEVEL FRONT OF CONVERGENCE TO IFRS IN LISTED COMPANIES IN BM & FBOVESPA
por: Ramos, Fernando Maciel, et al.
Publicado em: (2016) -
BOARD OF DIRECTORS AND AUDIT COMMITTEE CHARACTERISTICS OF LISTED COMPANIES ON THE BM&FBOVESPA
por: Reyes, Marilbeth Carolina Rodríguez, et al.
Publicado em: (2018)